Elixirgen Therapeutics, Inc.
Biotechnology company · Baltimore, Maryland, United States
Elixirgen Therapeutics, Inc. is a biotechnology company headquartered in Baltimore, Maryland, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2025.
Elixirgen Therapeutics at a glance
What does Elixirgen Therapeutics do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $4 million sold (2025).
Frequently asked questions about Elixirgen Therapeutics
Where is Elixirgen Therapeutics headquartered?
Elixirgen Therapeutics, Inc. is headquartered in Baltimore, Maryland, United States.
What does Elixirgen Therapeutics do?
Elixirgen Therapeutics, Inc. is a biotechnology company.
When was Elixirgen Therapeutics founded?
The earliest incorporation on record for Elixirgen Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- CoolTechBaltimore, Maryland, United States
- Gliknik IncBaltimore, Maryland, United States
- AgeneBio, Inc.Baltimore, Maryland, United States
- Gemstone BioTherapeutics, LLCBaltimore, Maryland, United States
- Pathovax LLCBaltimore, Maryland, United States
- Kubanda Cryotherapy, Inc.Baltimore, Maryland, United States
- Perceptive Navigation LLCBaltimore, Maryland, United States
- Sonosa Medical, Inc.Baltimore, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences